Safety Study of Lifitegrast to Treat Dry Eye

NCT01636206 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Disease

Interventions

DRUG: Lifitegrast
DRUG: Placebo

Sponsor

Shire